Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

55 North Mining Announces Closing of Flow-Through Financing

February 28, 2026

Crypto Market Update: Regulatory Holdup Pulls US$952 Million...

December 23, 2025

Columbia Partnership Accelerates U.S. Rare Earth & Critical...

November 17, 2025

Silver Price Surges Past US$56 to New All-time...

November 29, 2025

Trump’s Fed Feud: Fears Over Fed Independence Benefit...

November 12, 2025

Tech Weekly: Stocks See Minor Reprieve Before Ending...

February 28, 2026

RETRANSMISSION: LaFleur Minerals Upsizes LIFE and Flow-Through Unit...

December 19, 2025

Top 5 Canadian Mining Stocks This Week: Giant...

February 7, 2026

White House Unveils 90 Point AI Strategy

July 24, 2025

Finlay Minerals Announces Grant of Stock Options

December 11, 2025